Document Detail

Dobutamine stress echocardiography can predict reversible ventricular dysfunction after acute myocardial infarction.
MedLine Citation:
PMID:  16450796     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The aim of early treatment of acute myocardial infarction (AMI) is to achieve the rapid reperfusion of the culprit artery, which correlates with improvement in ventricular function and survival. With the widespread use of thrombolytic agents or coronary angioplasty as reperfusion strategies for AMI, it is possible to reduce the amount of myocardial necrosis. HYPOTHESIS: The assessment of residual viability with dobutamine stress echocardiography (DSE) in the infarcted area after AMI is relevant to subsequent management and prognosis. METHODS: Thirty-seven patients with AMI (mean age 59 +/- 12, 31 male, 22 with anterior AMI, 15 with inferior AMI) admitted to the coronary care unit within 3.8 +/- 1.8 h of the onset of symptoms were included. Two-dimensional echocardiography (2-D echo) study and DSE were performed at a mean of 4.7 +/- 1.8 days. Follow-up 2-D echo was performed at a mean of 25 +/- 11 days. To assess left ventricular regional systolic function, 2-D echo images were obtained at rest and during dobutamine-induced stress and were analyzed off-line according to the 13-segment model. Improvement in wall motion score (WMS) was defined by a decrease of at least two grades in the score. RESULTS: Wall motion score improved in 13 of the 37 patients after DSE (rest WMS 20.9 +/- 2.0 vs. D-WMS 17.7 +/- 2.2; p<0.001), which correlated with clinical or angiographic signs of reperfusion of the culprit vessel in all cases. Follow-up WMS evidenced a significant correlation with WMS after DSE (r = 0.91; p < 0.001). Sensitivity, specificity, and positive and negative predictive values of DSE in detecting patients whose left ventricular function (LVF) improved at 2-D echo follow-up were 72,96,92.8, and 82.7%, respectively. CONCLUSIONS: (1) Dobutamine stress echocardiography improved WMS in 35% of patients and correlated with signs of patency of the culprit vessel; (2) LVF improvement after dobutamine was predictive of late LVF recovery; (3) DSE can be a useful and safe tool for detecting reversible myocardial dysfunction after AMI.
Víctor M Mauro; Tomás F Cianciulli; Horacio A Prezioso; Sergio D Llanos Dethinne; Jorge H Leguizamón; Adrían A Charask; Enrique B Fairman; Yanina Castillo Costa; Carlos M Barrero
Related Documents :
15546286 - Stress echocardiography: basics and noninvasive assessment of myocardial viability.
9888756 - Assessment of myocardial response to pharmacologic interventions using an improved mr i...
10426326 - Significance of dobutamine-induced st-segment evaluation and t-wave pseudonormalization...
9168356 - Reproducibility of dobutamine digital stress echocardiography.
8962556 - Coronary flow reserve during coronary angioplasty in patients with a recent myocardial ...
10833706 - Infarct related artery patency: relation to serial electropharmacological studies and o...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Clinical cardiology     Volume:  28     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2006-02-02     Completed Date:  2006-05-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  523-8     Citation Subset:  IM    
Department of Cardiology, Clínica Bazterrica, Buenos Aires, Argentina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary
Blood Pressure / drug effects
Coronary Angiography
Coronary Care Units
Echocardiography, Stress*
Fibrinolytic Agents / therapeutic use
Follow-Up Studies
Heart Rate / drug effects
Middle Aged
Myocardial Infarction / drug therapy,  physiopathology*,  therapy*
Myocardial Reperfusion
Predictive Value of Tests
Research Design
Sensitivity and Specificity
Treatment Outcome
Ventricular Dysfunction, Left / ultrasonography*
Reg. No./Substance:
0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome usin...
Next Document:  Low rates of exercise in patients with metabolic syndrome after an acute coronary syndrome.